Basic Information
BERTIS Inc. has developed an AI-based diagnostic platform aimed at diagnosing cancer and heart diseases. The company's platform utilizes proteomics-based molecular diagnostic technology to discover biomarkers associated with cancer, enabling medical professionals to detect diseases at an early stage and treat them effectively.
BERTIS Inc.
Seongnam,GyeonggiProvince,SouthKorea
15~50 people
January 01, 2014
contact@bertis.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios